Insulin like growth factor-I in acute subarachnoid hemorrhage: A prospective cohort study

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Bendel, Stepani ^a   Koivisto, Timo ^a   Ryynänen, Olli Pekka ^a   Ruokonen, Esko ^a   Romppanen, Jarkko ^b   Kiviniemi, Vesa ^a   Uusaro, Ari ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOMATOMEDIN C; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1;

ACCURACY; ADULT; AGED; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; HYPONATREMIA; HYPOPHYSIS; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; BLOOD; COHORT ANALYSIS; GLASGOW COMA SCALE; INTRACRANIAL ANEURYSM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; BAYES THEOREM; COHORT STUDIES; FEMALE; GLASGOW COMA SCALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; YOUNG ADULT;

EID: 78149248087     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8988     Document Type: Article

References (34)

1. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009, 8:635-642. 10.1016/S1474-4422(09)70126-7, 19501022.
2. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 2007, 298:1429-1438. 10.1001/jama.298.12.1429, 17895459.
3. Bendel S, Koivisto T, Ruokonen E, Rinne J, Romppanen J, Vauhkonen I, Kiviniemi V, Uusaro A. Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: A prospective cohort study. Crit Care 2008, 12:R126. 10.1186/cc7084, 2592763, 18851750.
4. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavo S, Gasperi M, Scaroni C, De Marinis L, Benvenga S, Degli Uberti EC, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: Screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) 2004, 61:320-326. 10.1111/j.1365-2265.2004.02094.x, 15355447.
5. Espiner EA, Leikis R, Ferch RD, MacFarlane MR, Bonkowski JA, Frampton CM, Richards AM. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2002, 56:629-635. 10.1046/j.1365-2265.2002.01285.x, 12030914.
6. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg 2000, 93:743-752. 10.3171/jns.2000.93.5.0743, 11059653.
7. Brandt L, Saveland H, Valdemarsson S, Sjoholma H, Reinsturp P. Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF. Acta Neurol Scand 2004, 109:91-96. 10.1046/j.0001-6314.2003.00189.x, 14705969.
8. Tanriverdi F, Dagli AT, Karaca Z, Unluhirzarci K, Selcuklu A, Casanueva FF, Kelestimur F. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: A prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf) 2007, 67:931-937. 10.1111/j.1365-2265.2007.02989.x, 17666088.
9. Kreitschmann-Andermahr I, Poll E, Hutter BO, Reineke A, Kristes S, Gilsbach JM, Saller B. Quality of life and psychiatric sequelae following aneurysmal subarachnoid haemorrhage: Does neuroendocrine dysfunction play a role?. Clin Endocrinol (Oxf) 2007, 66:833-837. 10.1111/j.1365-2265.2007.02821.x, 17408419.
10. Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 2006, 17:305-323. 10.1016/j.cytogfr.2006.02.002, 16621671.
11. Kooijman R, Sarre S, Michotte Y, De Keyser J. Insulin-like growth factor I. A potential neuroprotective compound for the treatment of acute ischemic stroke?. Stroke 2009, 40:e83-88. 10.1161/STROKEAHA.108.528356, 19197073.
12. Aleman A, Torres-Alemán I. Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan. Prog Neurobiol 2009, 89:256-265. 10.1016/j.pneurobio.2009.07.008, 19665513.
13. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006, 26:1341-1353. 10.1038/sj.jcbfm.9600283, 16482081.
14. Baxter RC, Hawker FH, To C, Steward PM, Holman SR. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res 1998, 8:455-463. 10.1016/S1096-6374(98)80298-0, 10985757.
15. Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC, Valle D, Basaglia N, Degli Uberti EC. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 2006, 91:3928-3934. 10.1210/jc.2006-1040, 16882751.
16. Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valentini G, Hoffman AR, Ceda GP. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004, 117:312-317. 10.1016/j.amjmed.2004.02.049, 15336580.
17. van Rijn MJ, Slooter AJ, Bos MJ, Catarino CF, Koudstaal PJ, Hofman A, Breteler MM, van Duijn CM. Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: The rotterdam study. J Neurol Neurosurg Psychiatry 2006, 77:24-27. 10.1136/jnnp.2005.067447, 2117398, 16361587.
18. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001, 33:328-336. 10.3109/07853890109002086, 11491191.
19. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, . Hypos CCS Advisory Board, U.S.HypoCCS Study Group Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?. J Clin Endocrinol Metab 2002, 87:477-485. 10.1210/jc.87.2.477, 11836272, Hypos CCS Advisory Board, U.S.HypoCCS Study Group.
20. 15d-instrument. , http://www.15d-instrument.net/15d
21. Mattila AK, Saarni SI, Salminen JK, Huhtala H, Sintonen H, Joukamaa M. Alexithymia and health-related quality of life in a general population. Psychosomatics 2009, 50:59-68. 10.1176/appi.psy.50.1.59, 19213974.
22. Soini E, Rissanen T, Tiihonen J, Hodgins S, Eronen M, Ryynänen O-P. Predicting forensic admission among the mentally ill in a multinational setting: a Bayesian modelling approach. 2009, 68:1427-1440. Data & Knowledge Engineering.
23. Ng AY, Jordan MI. On discriminative vs. generative classifiers: a comparison of logistic regression and naive bayes. 2002, Cambridge, MIT press, Dietterich T, Becker S, Ghahramani Z.
24. Visser-Meily JM, Rhebergen ML, Rinkel GJ, van Zandvoort MJ, Post MW. Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage: relationship with psychological symptoms and personality characteristics. Stroke 2009, 40:1526-1529. 10.1161/STROKEAHA.108.531277, 19095984.
25. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 106:939-944. 10.1161/01.CIR.0000027563.44593.CC, 12186797.
26. de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelnet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC. Acute stress response in children with meningococcal sepsis: Important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 2002, 87:3118-3124. 10.1210/jc.87.7.3118, 12107211.
27. Brabant G, Wallaschofski H. Normal levels of serum IGF-I: Determinants and validity of current reference ranges. Pituitary 2007, 10:129-133. 10.1007/s11102-007-0035-9, 17487588.
28. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, Fusco A, Del Monte P, De Menis E, Faustini-Fustini M, Grimaldi F, Logoluso F, Razzore P, Rovere S, Benvenga S, Degli Uberti EC, De Marinis L, Lombardi G, Mantero F, Martino F, Martino E, Giordano G, Ghigo E. Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 2005, 90:6085-6092. 10.1210/jc.2005-0504, 16144947.
29. Popovic V. GH deficiency as the most common pituitary defect after TBI: clinical implications. Pituitary 2005, 8:239-243. 10.1007/s11102-006-6047-z, 16508711.
30. Gasco V, Corneli G, Rovere S, Croce C, Beccuti G, Mainolfi A, Grottoli S, Aimaretti G, Ghigo E. Diagnosis of adult GH deficiency. Pituitary 2008, 11:121-128. 10.1007/s11102-008-0110-x, 18404387.
31. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87:2067-2079. 10.1210/jc.87.5.2067, 11994342.
32. Ghigo E, Masel B, Aimaretti G, Leon-Carrion J, Casanueva FF, Dominguez-Morales MR, Elovic E, Perrone K, Stalla G, Thompson C, Urban R. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj 2005, 19:711-724. 10.1080/02699050400025315, 16195185.
33. Koivisto T, Vanninen R, Hurskainen H, Saari T, Hernesniemi J, Vapalahti M. Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study. Stroke 2000, 31:2369-2377.
34. O'Kelly CJ, Kulkarni AV, Austin PC, Wallace MC, Urbach D. The impact of therapeutic modality on outcomes following repair of ruptured intracranial aneurysms: an administrative data analysis. J Neurosurg 2009,